SCHEMBL31437044

SCHEMBL31437044

NC1CCN(S(=O)(=O)c2cccc(O)c2)CC1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.59
ALDH1A1 P00352 8/20 0.53
NPSR1 Q6W5P4 2/20 0.53
LMNA P02545 3/20 0.52
PKLR P30613 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MBTD1 Q05BQ5 1/20 0.47
L3MBTL3 Q96JM7 1/20 0.47
GAA P10253 1/20 0.47
TSHR P16473 2/20 0.47
HTT P42858 1/20 0.47
MAPT P10636 1/20 0.46
IL1RN P18510 1/20 0.46
HPGD P15428 1/20 0.45
CNR1 P21554 1/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24571882 1.00 PKM (0.59) PKMALDH1A1NPSR1LMNAPKLR
SCHEMBL7697937 0.91 PKM (0.53) PKMALDH1A1NPSR1LMNAPKLR
Hydrochloric Acid SCHEMBL7696531 0.90 PKM (0.52) PKMALDH1A1NPSR1LMNAPKLR
Hydrochloric Acid SCHEMBL7714208 0.90 PKM (0.52) PKMALDH1A1NPSR1LMNAPKLR
Hydrochloric Acid SCHEMBL7698673 0.90 PKM (0.52) PKMALDH1A1NPSR1LMNAPKLR
SCHEMBL28656967 0.82 SMN1; SMN2 (0.60) PKMALDH1A1NPSR1LMNAPKLR
SCHEMBL1333248 0.81 MAPT (0.72) ALDH1A1LMNASMN1; SMN2KMT2AMEN1
SCHEMBL29077495 0.81 ALDH1A1 (0.53) PKMALDH1A1NPSR1LMNAPKLR
Hydrochloric Acid SCHEMBL7696017 0.81 ALDH1A1 (0.67) PKMALDH1A1NPSR1LMNASMN1; SMN2
SCHEMBL4704361 0.80 GAA (0.61) PKMALDH1A1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235261-A1 BIFUNCTIONAL COMPOUNDS CONTAINING 2,4,5-SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CERTAIN CYCLIN-DEPENDENT KINASE VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2025-11-13 WO disclosed
CN-120152967-A Bifunctional compounds containing 2, 5-substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-06-13 CN disclosed
CN-119630644-A Bifunctional compounds containing pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed
CN-119630651-A Bifunctional compounds containing substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed